Propanc Biopharma undertaking PRP manufacturing & development for human use
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection
Avacc 3 has significant advantages over existing whooping cough vaccines
Company has invested $150 million to build a 150,000 square-foot commercial manufacturing facility in Research Triangle Park (RTP), North Carolina
Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Subscribe To Our Newsletter & Stay Updated